Ergoteles LLC Precigen, Inc. Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.15 - $2.53 $14,259 - $31,371	-12,400 Reduced 8.83%	128,000 $172,000
Q1 2022 May 13, 2022	BUY	$1.91 - $3.98 $268,164 - $558,792	140,400 New	140,400 $296,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $143,339 - $223,333	-40,606 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $202,623 - $265,969	40,606 New	40,606 $203,000
Q2 2021 Aug 12, 2021	SELL	$6.24 - $8.22 $900,369 - $1.19 Million	-144,290 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$6.74 - $10.95 $972,514 - $1.58 Million	144,290 New	144,290 $994,000
Q4 2020 Feb 11, 2021	SELL	$3.75 - $10.56 $158,643 - $446,740	-42,305 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $148,067 - $262,291	42,305 New	42,305 $148,000

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.